Skip to content

Contact +44 (0) 20 7060 7474 email us

Animal / Veterinary

Veterinary Health Markets

 

Publication Date December 2008
Publisher TriMark Publications
Product Type Report
Pages 303
ISBN Number TMRVET04-1008
Product Code TRI00008

Price

£2,075.00
approximately: $3,401 | €2,420

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

Profound changes are happening in the animal health market. Pet owners in the United States are demanding more advanced and expensive treatments for companion animals, driving growth in the companion-animal sector. At the same time, concerns about livestock health care and feeding are driving changes in industrial animal husbandry. This TriMark Publications report offers a broad, yet detailed, overview of the shape of the veterinary health products market over the next several years. Examining both livestock and companion-animal markets. The overall market for veterinary therapeutics and diagnostic products has grown dramatically. This report analyzes the U.S. veterinary pharmaceuticals and diagnostics markets. The report outlines market size, market growth, forecasts, and competitive information. Focusing both on companion (pet) animal markets and agricultural livestock, the report examines the markets for pharmaceuticals, vaccines, diagnostics, and feed additives. The study reveals: the size of the markets for companion-animal products, broken down by type of animal (i.e., cats, dogs, small animals, etc.); size of the markets for livestock products; how the Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA) regulations impact these markets; the identity of the top market players, along with their market shares and future prospects; how the antibiotic feed additive controversy is influencing the agricultural market; and key players in the veterinary pharma and diagnostic markets.

Contents

  • 1. Overview
    • 1.1 Objective of Report
    • 1.2 Scope of Report
    • 1.3 Methodology
    • 1.4 Executive Summary
  • 2. Veterinary Biological Products
    • 2.1 Overview of Health Products Market
      • 2.1.1 World Products Markets
      • 2.1.2 U.S. Animal Health Products Market
      • 2.1.3 European Animal Health Markets
      • 2.1.4 Asian Animal Health Products Markets
      • 2.1.5 Rest of World
      • 2.1.6 World Market Share
      • 2.1.7 Common Animal Diseases
      • 2.1.8 Companion Animals
    • 2.2 Veterinary Vaccines
      • 2.2.1 Major Canine Vaccines
      • 2.2.2 Major Feline Vaccines
    • 2.3 Agricultural Animals
      • 2.3.1 Major Cattle Vaccines
      • 2.3.2 Major Poultry Vaccines
      • 2.3.3 Major Sheep Vaccines
      • 2.3.4 Major Swine Vaccines
      • 2.3.5 Horses
    • 2.4 Trends in the Biologicals Market
    • 2.5 Nutraceuticals
      • 2.5.1 Nutraceutical Market for Companion Animals
    • 2.6 OTC Animal Health Global Market Opportunity
  • 3. Veterinary Pharmaceutical Products
    • 3.1 Overview
      • 3.1.1 Pharmaceutical Products for Dogs and Cats
        • 3.1.1.1 Antiparasitics
        • 3.1.1.2 Antibiotics
        • 3.1.1.3 Anti-Inflammatories
        • 3.1.1.4 Chronic Care Products
        • 3.1.1.5 Cardiovasculars
        • 3.1.1.6 GI Products
        • 3.1.1.7 Endocrine Products
        • 3.1.1.8 Anti-Infectives
        • 3.1.1.9 Behavior Modifiers
        • 3.1.1.10 Anthelminitics
        • 3.1.1.11 Antifungals
        • 3.1.1.12 Cancer and Chemotherapy in Companion Animals
      • 3.1.2 Pharmaceutical Products for Agricultural Animals
        • 3.1.2.1 Antiparasites
        • 3.1.2.2 Antibiotics
        • 3.1.2.3 Insecticides
    • 3.2 Leading Products and Competitors
      • 3.2.1 Elanco
      • 3.2.2 Novartis
      • 3.2.3 Alpharma
      • 3.2.4 Wyeth
      • 3.2.5 Pfizer Animal Health
    • 3.3 Veterinary Pharmaceutical Market Trends
    • 3.4 Companion-Animal Crossover Products
    • 3.5 Generics in the Animal Health Sector
  • 4. Veterinary Feed Additive Products
    • 4.1 Overview
    • 4.2 U.S. Feed Additives Market
    • 4.3 Leading Feed Additives and Competitors
    • 4.4 Feed Additives Market Trends
      • 4.4.1 Livestock Performance Enhancers
    • 4.5 Pet Food Additives and Contaminants
      • 4.5.1 Pet Deaths
      • 4.5.2 The FDA Response
  • 5. Veterinary Diagnostic Test Products
    • 5.1 Introduction
    • 5.2 Veterinary Diagnostic Market Size and Growth Rates
      • 5.2.1 Market Drivers
      • 5.2.2 Immunodiagnostic and Nucleic Acid Testing Markets
        • 5.2.2.1 Market Size and Growth
      • 5.2.3 Technological Developments in the Diagnostic Industry
    • 5.3 Competitive Situation
    • 5.4 Estimate of Units Sold and Pricing
    • 5.5 PCR Applications for Veterinary Use
    • 5.6 Companion-Animal Diagnostics
      • 5.6.1 Feline Leukemia Virus
    • 5.7 Agricultural Animal Diagnostics
    • 5.8 U.S. Diagnostic Test Market
    • 5.9 Leading Competitors in Diagnostic Testing
    • 5.10 Veterinary Diagnostic Market Trends
    • 5.11 Collaborative Licensing
    • 5.12 BSE Diagnostic Tests
    • 5.13 West Nile Virus Diagnostic Tests
    • 5.14 Avian Flu Diagnostic Tests
  • 6. Overview of the Veterinary Health Market
    • 6.1 Regulatory Environment
      • 6.1.1 International Bodies for Regulation of Animal Health Products
        • 6.1.1.1 Regulation of Animal Health Products in the E.U
        • 6.1.1.2 Regulation of Animal Health Products in the U.S
        • 6.1.1.3 Regulation of Animal Health Products in Japan
      • 6.1.2 Proposed Regulation of Animal Antibiotics
    • 6.2 The European Animal Health Industry
      • 6.2.1 Trends Driving Demand
        • 6.2.1.1 European, International and U.S. Oversight of Veterinary Medicines
        • 6.2.1.2 Antibiotic Usage
    • 6.3 Mergers and Acquisitions
    • 6.4 New Product Launches
    • 6.5 Bioterrorism and Foodborne PathogensWHO Guidelines
      • 6.5.1 The U.S. Bioterrorism Preparedness and Response Act, 2002
    • 6.6 Generic Products
  • 7. Emerging Markets
    • 7.1 Biotechnology and Veterinary Health
      • 7.1.1 Biotechnology and Biologics
        • 7.1.1.1 Recombinant DNA Vaccines
        • 7.1.1.2 Plant-derived Vaccines
      • 7.1.2 DNA Probes
      • 7.1.3 Biotechnology and Pharmaceuticals
        • 7.1.3.1 Immunodiagnostic Applications
        • 7.1.3.2 Growth Enhancers
    • 7.2 Impact of Genomics on Veterinary Health
      • 7.2.1 Autosomal Dominant Traits
      • 7.2.2 X-Linked Traits
      • 7.2.3 Autosomal Recessive Traits
      • 7.2.4 Current DNA Testing in Animals
      • 7.2.5 Direct DNA Testing: Mutation-based Tests
      • 7.2.6 Indirect DNA Testing: Linkage-based or Marker-Based Tests
    • 7.3 Companion-Animal Markets
    • 7.4 Alternative Medicine in Veterinary Practice
    • 7.5 Generics in the Animal Health Market
    • 7.6 Pet Insurance
    • 7.7 Orthotics and Prosthetics for Animals
    • 7.8 Pet Cloning
  • 8. Company Profiles
    • 8.1 Abaxis, Inc
    • 8.2 Abbott Laboratories
    • 8.3 Adiagene
    • 8.4 Agricultural Research Service
    • 8.5 Alpharma, Inc
    • 8.6 Avian Biotech
    • 8.7 BASF
    • 8.8 Bayer Animal Health
    • 8.9 Biobest Laboratories
    • 8.10 BioVet, Inc
    • 8.11 Boehringer Ingelheim Corp
    • 8.12 CEVA Sant Animale
    • 8.13 Cypress Diagnostics
    • 8.14 Dabaco Viet Nam Corporation
    • 8.15 DayMoon Industries, Inc
    • 8.16 Dow AgroSciences LLC
    • 8.17 Dupont Qualicon
    • 8.18 Egyptian International Pharmaceutical Industries Company
    • 8.19 Elanco Animal Health
    • 8.20 Eurofins Medigenomix GmbH
    • 8.21 Fort Dodge Animal Health
    • 8.22 Gene Check, Inc
    • 8.23 Heska
    • 8.24 Huvepharma
    • 8.25 IDEXX Laboratories, Inc
    • 8.26 Intervet/Schering-Plough Animal Health
    • 8.27 IWAKI & Co., Ltd
    • 8.28 Janssen Pharmaceutica
    • 8.29 Laboklin
    • 8.30 Medika d.d
    • 8.31 Merial
    • 8.32 MetaMorphix, Inc
    • 8.33 Microbix Biosystems, Inc
    • 8.34 Momina krepost AD Veliko Tarnovo
    • 8.35 Monsanto
    • 8.36 Mosaic Company
    • 8.37 Neogen Corporation
    • 8.38 Novartis Animal Health
    • 8.39 OptiGen
    • 8.40 Orion Corporation
    • 8.41 PETCO Animal Supplies, Inc
    • 8.42 PetSmart, Inc
    • 8.43 Pfizer Animal Health
    • 8.44 Phylaxia Pharma NyRt
    • 8.45 Sanofi-Aventis
    • 8.46 Schering-Plough Animal Health Corporation
    • 8.47 Skystar Bio-Pharmaceutical Company
    • 8.48 Sunwin International Nutraceuticals
    • 8.49 Synbiotics Corporation
    • 8.50 Teva Pharmaceutical Industries Ltd
    • 8.51 The Arab Pesticides and Veterinary Drugs Mfg. Co
    • 8.52 ThermoGenesis Corp
    • 8.53 VCA Antech, Inc
    • 8.54 Velefarm ad Beograd
    • 8.55 Veterinarski Zavod Subotica ad Subotica
    • 8.56 Vtoquinol
    • 8.57 Virbac SA
    • 8.58 WooGene B&G Co., Ltd
    • 8.59 Wyeth
  • 9. Business Trends in the Industry
    • 9.1 Animal Health Additive Growth Trends
    • 9.2 Move to Complete Product Portfolio
    • 9.3 Reduced Antibiotic Usage in Animal Feeds
    • 9.4 European Animal Health Industry
    • 9.5 Licensing and Partnership Opportunities in Animal Health R&D
  • 10. Company Directory
    • Appendix 1: Dosages for Selected Drugs Alphabetical Listing
    • Appendix 2: Trade Names
    • Appendix 3: Abbreviations
  • INDEX OF FIGURES
    • Figure 2.1: Global Animal Health Market by Product Category, 2007
    • Figure 2.2: Worldwide Sales of Animal Health Products by Product Class, 2007
    • Figure 2.3: Worldwide Animal Health Industry Revenues by Species, 2007
    • Figure 2.4: Worldwide Animal Health Products Market by Region, 2007
    • Figure 2.5: Market Share for the Top Ten Animal Health Companies, 2007
    • Figure 2.6: U.S. Companion Animal Healthcare Products Share of Overall Animal Health Product Sales, 2007
    • Figure 2.7: Pet Population in Japan, 1996 and 2006
    • Figure 2.8: Swine Population in Japan, 2006-2008
    • Figure 2.9: Cattle Population in Japan, 2006-2008
    • Figure 2.10: The Indian Biologicals Industry by Product Category, 2007
    • Figure 2.11: South African Animal Health Market by Product Category, 2007
    • Figure 2.12: Global Incidence of Avian H5N1, 2008
    • Figure 2.13: Global incidence of Equine Herpesvirus Type 1, 2008
    • Figure 2.14: Global Outbreaks of Equine Viral Arteritis, 2008
    • Figure 3.1: Animal Health Product Sales in the U.S., 2005-2014
    • Figure 3.2: Expenditure on Pets in Australia by Pet Type, 2005
    • Figure 3.3: Pet care Expenditure in Australia by Category, 2005
    • Figure 3.4: The European Parasiticide Market by Product Category, 2007
    • Figure 3.5: Growth in Global Sales of Antibiotic Products, 2005-2012
    • Figure 3.6: Novartis Animal Health Division: Business Split, 2007
    • Figure 3.7: Novartis Animal Health Division: Product Split, 2007
    • Figure 3.8: Novartis Animal Health Division: Sales by Geographic Region, 2007
    • Figure 4.1: Global Market for Livestock Performance Enhancers, 2006
    • Figure 5.1: Growth of the Lateral Flow Diagnostic Tests in the Veterinary Market, 2005-2015
    • Figure 7.1: The U.S. Market for Companion Animal Pharmaceuticals, 2007
    • Figure 7.2: U.S. Companion Animal Pharmaceuticals: Percentage of New Generics, 2007
    • Figure 7.3: U.S. Market for FDA-approved Pharmaceuticals for Companion Animals, 2007
  • LIST OF TABLES
    • Table 2.1: World Market for Animal Health Products, 2002-2012
    • Table 2.2: Global Sales of Animal Health and Nutrition Products, 2004-2012
    • Table 2.3: Worldwide Animal Health Products Market by Region, 2007
    • Table 2.4: U.S. Animal Health Product Sales, 2005-2014
    • Table 2.5: Animal Health Market: Sales Statistics-Europe, 2007
    • Table 2.6: E.U. Animal Health Market, 2004-2014
    • Table 2.7: Japanese Animal Health Market, 2000-2012
    • Table 2.8: Chinese Animal Health Products Market, 2005-2012
    • Table 2.9: Indian Animal Health Market, 2003-2010
    • Table 2.10: Institutions Involved in Manufacturing Vaccines and Other Biological Products for Livestock
    • Table 2.11: Worldwide Animal Health Product Sales for Leading Producers, 2007
    • Table 2.12: Common Animal Diseases
    • Table 2.13: Cattle Diseases
    • Table 2.14: Sheep and Goat Diseases
    • Table 2.15: Equine Diseases
    • Table 2.16: Swine Diseases
    • Table 2.17: Avian Diseases
    • Table 2.18: Fish Diseases
    • Table 2.19: Other Veterinary Diseases
    • Table 2.20: Leading Companion-Animal Prescription Drugs by Sales, 2007
    • Table 2.21: Worldwide Veterinary Vaccine Market, 2005-2012
    • Table 2.22: U.S. Veterinary Vaccine Market, 2004-2013
    • Table 2.23: Second-Generation Licensed/Commercialized Veterinary Viral Vaccines
    • Table 2.24: Canine Vaccinations
    • Table 2.25: Dog Vaccine Price List
    • Table 2.26: American Association of Feline Practitioners 2006 Feline Vaccination Guidelines: Summary of Vaccination in General Practice
    • Table 2.27: Recently Commercialized Veterinary Bacterial Vaccines
    • Table 2.28: Available Veterinary Live Protozoal Vaccines
    • Table 2.29: Available Veterinary Killed/Subunit Protozoal Vaccines
    • Table 2.30: Commercialized Reproduction Control Vaccines
    • Table 2.31: Global Market for Nutraceutical in Companion Animals, 2005-2012
    • Table 3.1: Veterinary Drugs Listed by Therapeutic Class
    • Table 3.2: Sales of Pharmaceutical Products for Animal Health in the U.S., 2000-2008
    • Table 3.3: Number of Dogs in the U.S., 1996-2008
    • Table 3.4: Number of Pet Dogs by Geographical Region, 2008
    • Table 3.5: Number of Cats in the U.S., 1996-2008
    • Table 3.6: Number of Pet Cats by Geographical Region, 2008
    • Table 3.7: U.S. Spending on Pet Care, 1996-2008
    • Table 3.8: American Veterinary Specialists
    • Table 3.9: Companion-Animal Products Sales, 2008
    • Table 3.10: U.S. Antiparistic Animal Health Product Sales, 2005-2012
    • Table 3.11: Global Antiparistic Animal Health Product Sales, 2005-2012
    • Table 3.12: Worldwide Sales of Animal Health Antibiotics, 2005-2012
    • Table 3.13: U.S. Volume of Animal Health Antibiotics Used, 2000-2006
    • Table 3.14: U.S. Sales of Animal Health Antibiotics, 2005-2012
    • Table 3.15: European Sales of Animal Health Antibiotics, 2005-2012
    • Table 3.16: Common Veterinary Anti-Inflammatories
    • Table 3.17: U.S. Pet Anti-Inflammatory Market, 2003-2012
    • Table 3.18: Retail Pricing of Rimadyl
    • Table 3.19: EtoGesic Pricing
    • Table 3.20: Therapy for Various Pet Cancers
    • Table 3.21: Mechanisms of Action, Indications and Toxicities of Selected Antineoplastic Agents
    • Table 3.22: Treatment Options for Canine or Feline Lymphomas
    • Table 3.23: Chemotherapeutic Agents Commonly Used in Veterinary Medicine, and the Associated Risks
    • Table 3.24: Bacterial and Protozoal Threats to Poultry
    • Table 3.25: Bacterial and Protozoal Threats to Pigs
    • Table 3.26: Elanco Veterinary Products Summary
    • Table 3.27: Wyeth Fort Dodge Animal Health Products
    • Table 4.1: Global Sales of Feed Additives for Animal Health, 2005-2014
    • Table 4.2: Target Species and Brand Names for Probiotics
    • Table 4.3: Feed AdditivesAntimicrobials and Growth Promotants
    • Table 4.4: Feed AdditivesAnthelmintics
    • Table 4.5: U.S. Beef Exports, 2002-2007
    • Table 4.6: Retail Equivalent Value of U.S. Beef Industry, 2002-2007
    • Table 4.7: U.S. Revenues from Animal Agriculture by State, 2006
    • Table 4.8: Use of Antibiotics as Growth Promotants
    • Table 4.9: Global Market for Livestock Performance Enhancers, 2004-2010
    • Table 5.1: Veterinary Diagnostics World Market, 2005-2012
    • Table 5.2: Veterinary Immunodiagnostic Testing World Markets, 2005-2012
    • Table 7.1: Labs that Perform Canine DNA Testing
    • Table 7.2: DNA (Mutation) Tests for Canine Inherited Diseases
    • Table 7.3: DNA (Marker) Tests for Canine Inherited Diseases
    • Table 7.4: U.S. Companion Animal Prescription Drug Revenue, 2006
    • Table 7.5: Companies Producing Generic Pharmaceuticals for Animal Health
    • Table 7.6: Generics vs. Branded Animal Health Pharmaceuticals, 2005
    • Table 7.7: U.S. Animal Health Generic Pharmaceuticals in the Pipeline, 2007
    • Table 7.8: Veterinary Pet Insurance Rates and Coverage in the U.S., 2008
    • Table 8.1: Pfizer Animal Health Products
    • Table 8.2: Pfizer Products Patents
    • Table 8.3: Key Pfizer Animal Health Products
    • Table 8.4: Pfizer Livestock Products
    • Table 8.5: Pfizer Equine Products
    • Table 8.6: Pfizer Companion Animal Products
    • Table 9.1: European Animal Health Market Sales, 2005-2012